Compare FMC Corp (FMC) vs Microsoft (MSFT) Price & Performance

FMC Corporation (FMC) trades at $11.61, up 8.3% today, but remains in a challenging fundamental position with a net income margin of -72.93% and negative ROE of -80.78% for 2025. The company is actively restructuring, securing a $400 million minority investment from Tessenderlo Group and planning a $114 million property sale to reduce its $3.03 billion long-term debt. Technical indicators are bearish, with the stock trading near key support at $11. Recent news highlights progress on its new herbicide, rimisoxafen, including a regulatory submission to the EPA and a partnership with Corteva.

The outlook is cautious. While aggressive debt reduction and new product pipelines offer potential, deep losses and declining revenue pose significant risks. The analyst consensus is mixed (47.6% Buy, 50% Hold) with a $16 price target, suggesting modest upside if turnaround efforts succeed, but high execution risk remains the primary concern for investors.

Microsoft (MSFT) trades at $400.42, up 4.02% today, with a bullish technical outlook and strong fundamentals. The stock has consistently beaten earnings estimates, with Q1 2026 EPS of $4.27 exceeding the $4.06 forecast. Revenue grew to $281.72 billion in 2025, and net income reached $101.83 billion. Analyst consensus is strongly bullish with an 80.49% buy rating and a $547.23 price target. Recent news highlights AI leadership and Azure momentum, though concerns over capital expenditures persist.

Outlook remains positive driven by AI integration and cloud growth, but risks include heightened competition and macroeconomic volatility. The stock offers solid upside to the consensus target, supported by robust cash flow and dividend payments. Investors should weigh execution risks against long-term growth potential in the evolving tech landscape.